ATP6V1G2 and central nervous system cancer: Also, K–M curves in 313 gliomas sample through CGGA database showed that low expression of ATP6V1G2, GABARAPL1 and GOT1 was associated with poor prognosis (Fig. 8D), which was consistent with the results from the TCGA database.